Mifepristone challenges have hit repeated snags at Supreme Court on legal standing, and appeals court that twice ruled relaxed prescribing rules violated regulatory procedure is wary of getting overturned again.
Mary and Andrew begin this week by addressing Todd Blanche’s “Meet the Press” interview with Kristen Welker, where, among other things, the newly appointed Attorney General proclaimed that “no attorney general should ever pledge” to act independently of the White House, despite decades of post-Watergate reforms. Keeping in the Blanche vicinity, the co-hosts detail a complaint filed by former Michigan AUSA Sunita Doddamani, who alleged she was fired without cause simply for doing her job prosecuting FACE Act violations. Then, a dive into revelations of undercover agents targeting Minnesota nonprofit organizations as part of an investigation that led to indictments of protestors that, in Mary’s view, included “a whole lot of…
The 5th U.S. Circuit Court of Appeals ruled recently that the federal ban against home whiskey distilleries is unconstitutional. However, the 6th Circuit upheld the federal ban.
The Supreme Court extended a freeze Monday on new restrictions for dispensing the widely used abortion pill mifepristone , allowing the continued mail-order prescribing of the drug. Why it matters: The extension, which runs through 5 p.m. Thursday, provides a reprieve for pharmacies, telehealth companies and clinicians caught up in the latest legal tussle over accessing the pill. Driving the news: Justice Samuel Alito extended a stay he granted a week ago in response to requests from drugmakers Danco Laboratories and GenBioPro to restore access to mifepristone via teleprescribing and the mails. - Anti-abortion advocates have been calling for a rollback of a Biden administration policy that expanded access to mifepristone and removed a…
Nationwide access to abortion pills is again in legal limbo, almost two years after the Supreme Court threw out a case challenging mail-order prescribing of the widely used drug mifepristone. Why it matters: A circuit court ruling on Friday that dramatically dialed back access to the drug has caused confusion for pharmacies, telehealth companies and other clinicians, even in states where abortion is legal. - Some providers are stopping their prescriptions, others are switching to different drugs, and patients are left wondering what's coming next. - While the Supreme Court on Monday froze that decision for a week, it could rule as soon as next week that the drug can only be dispensed in person. The big picture: Regardless of what…